Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
51
HOLX Quote, Financials, Valuation and Earnings
Last price:
$74.50
Seasonality move
:
8.58%
Day range:
$74.19 - $74.62
52-week range:
$51.90 - $75.34
Dividend yield:
0%
P/E ratio:
30.00x
P/S ratio:
4.13x
P/B ratio:
3.29x
Volume:
5.9M
Avg. volume:
3.2M
1-year change:
2.5%
Market cap:
$16.6B
Revenue:
$4.1B
EPS (TTM):
$2.48
Analysts' Opinion
-
Consensus RatingHologic, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 15 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $76.50, Hologic, Inc. has an estimated upside of 2.69% from its current price of $74.50.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $70.00 representing 6.04% downside risk from its current price of $74.50.
Fair Value
-
According to the consensus of 18 analysts, Hologic, Inc. has 2.69% upside to fair value with a price target of $76.50 per share.
HOLX vs. S&P 500
-
Over the past 5 trading days, Hologic, Inc. has underperformed the S&P 500 by -1.97% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Hologic, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hologic, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Hologic, Inc. reported revenues of $1B.
Earnings Growth
-
Hologic, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Hologic, Inc. reported earnings per share of $0.83.
Enterprise value:
17B
EV / Invested capital:
2.22x
Price / LTM sales:
4.13x
EV / EBIT:
17.58x
EV / Revenue:
4.15x
PEG ratio (5yr expected):
1.31x
EV / Free cash flow:
18.82x
Price / Operating cash flow:
18.72x
Enterprise value / EBITDA:
13.53x
Gross Profit (TTM):
$2.3B
Return On Assets:
6.39%
Net Income Margin (TTM):
13.8%
Return On Equity:
11.59%
Return On Invested Capital:
7.59%
Operating Margin:
24.11%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $4B | $4B | $4.1B | $987.9M | $1B | |
| Gross Profit | $2.2B | $2.2B | $2.3B | $552.8M | $580.7M | |
| Operating Income | $941.1M | $970.2M | $968.9M | $236.3M | $253M | |
| EBITDA | $1.3B | $1.3B | $1.3B | $310.8M | $322.7M | |
| Diluted EPS | $1.83 | $3.32 | $2.48 | $0.76 | $0.83 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.2B | $3.9B | $4.2B | $3.8B | $3.7B | |
| Total Assets | $8.9B | $9.1B | $9.1B | $9.2B | $9B | |
| Current Liabilities | $1.3B | $937.7M | $1.2B | $1B | $977.2M | |
| Total Liabilities | $4.7B | $4.2B | $4.1B | $4B | $4B | |
| Total Equity | $4.2B | $4.9B | $5B | $5.1B | $5B | |
| Total Debt | $3.1B | $2.9B | $2.9B | $2.6B | $2.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $1.3B | $1.1B | $367M | $355.1M | |
| Cash From Investing | -$152.1M | -$781M | -$482.7M | -$595.7M | -$132.1M | |
| Cash From Financing | -$483.2M | -$1.1B | -$777.2M | -$56.8M | $1.6M | |
| Free Cash Flow | $901M | $1.1B | $904.7M | $336.7M | $324.7M | |
HOLX
Sector
Market Cap
$16.6B
$28.1M
Price % of 52-Week High
98.89%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
4.66%
-1.49%
1-Year Price Total Return
2.5%
-17.13%
Beta (5-Year)
0.703
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$74.91
200-day SMA
Buy
Level
$66.01
Bollinger Bands (100)
Buy
Level
66.82 - 74.34
Chaikin Money Flow
Buy
Level
605.3M
20-day SMA
Sell
Level
$74.90
Relative Strength Index (RSI14)
Sell
Level
49.19
ADX Line
Sell
Level
34.93
Williams %R
Neutral
Level
-73.0435
50-day SMA
Buy
Level
$74.08
MACD (12, 26)
Buy
Level
0.28
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
444.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.9694)
Buy
CA Score
(Annual)
Level (0.4684)
Buy
Beneish M-Score
(Annual)
Level (-2.7291)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.404)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Stock Forecast FAQ
In the current month, HOLX has received 3 Buy ratings 15 Hold ratings, and 0 Sell ratings. The HOLX average analyst price target in the past 3 months is $76.50.
-
Where Will Hologic, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hologic, Inc. share price will rise to $76.50 per share over the next 12 months.
-
What Do Analysts Say About Hologic, Inc.?
Analysts are divided on their view about Hologic, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hologic, Inc. is a Sell and believe this share price will drop from its current level to $70.00.
-
What Is Hologic, Inc.'s Price Target?
The price target for Hologic, Inc. over the next 1-year time period is forecast to be $76.50 according to 18 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 15 analysts rate the stock a Hold.
-
Is HOLX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hologic, Inc. is a Hold. 15 of 18 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HOLX?
You can purchase shares of Hologic, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hologic, Inc. shares.
-
What Is The Hologic, Inc. Share Price Today?
Hologic, Inc. was last trading at $74.50 per share. This represents the most recent stock quote for Hologic, Inc.. Yesterday, Hologic, Inc. closed at $74.50 per share.
-
How To Buy Hologic, Inc. Stock Online?
In order to purchase Hologic, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HOLX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HOLX
Sector
P/E ratio
30.00x
23.89x
PEG ratio
1.31x
-0.01x
P/B ratio
3.29x
1.81x
Price / LTM sales
4.13x
1.59x
Growth Metrics
HOLX
Sector
Revenue growth
6.24%
4.62%
Earnings growth
9.63%
11.06%
Revenue (5-year growth)
1.66%
6.5%
Earnings forecast
$1.10
-$0.21
Profitability
HOLX
Sector
Profitability FY 2025
$2.3B
$3.6M
Return on invested capital
7.59%
-31.84%
Return on assets
6.39%
-27.96%
Return on equity
11.59%
-37.63%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
2
Balance Sheet
HOLX
Sector
Total cash
$2.2B
$26.4M
Short term investments
$173.4M
$25.7M
Total assets
$9B
$76.9M
Long term debt
$2.6B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
